Electromedical Technologies (Electromedical Technologies) Cash And Cash Equivalents : $0.09 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Electromedical Technologies Cash And Cash Equivalents?

Electromedical Technologies's quarterly cash and cash equivalents declined from Jun. 2023 ($0.42 Mil) to Sep. 2023 ($0.14 Mil) but then stayed the same from Sep. 2023 ($0.14 Mil) to Dec. 2023 ($0.09 Mil).

Electromedical Technologies's annual cash and cash equivalents declined from Dec. 2021 ($0.38 Mil) to Dec. 2022 ($0.37 Mil) and declined from Dec. 2022 ($0.37 Mil) to Dec. 2023 ($0.09 Mil).

Electromedical Technologies Cash And Cash Equivalents Historical Data

The historical data trend for Electromedical Technologies's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Electromedical Technologies Cash And Cash Equivalents Chart

Electromedical Technologies Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

0.27

0.38

0.37

0.09

Electromedical Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial														0.37	1.24	0.42	0.14	0.09

Electromedical Technologies Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Electromedical Technologies (OTCPK:EMED) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Electromedical Technologies Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Electromedical Technologies's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Electromedical Technologies (Electromedical Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Electromedical Technologies Inc (OTCPK:EMED) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

16561 North 92nd Street, Suite 101, Scottsdale, AZ, USA, 85260

Website

https://www.electromedtech.com

Electromedical Technologies Inc is a bioelectronics manufacturing company. It designs and develops simple-to-use bioelectronics therapy devices, which in major cases provide immediate and long-lasting pain relief across the broadest range of ailments. Its focuses on improving global wellness for people suffering from various painful conditions. It Develops and manufactures bioelectronics products.

Executives

Hymers Iii R. Leslie	director	520 S GRAND AVENUE, STE 320, LOS ANGELES CA 90071
Lee Benson	director	PO BOX 41828, MESA AZ 41828
Donald J Steinberg	10 percent owner	3223 SUMAC ROAD, FALLBROOK CA 92028
Matthew Wolfson	director, officer: CEO, CFO	16561 N. 92ND STREET, STE. 101, SCOTTSDALE AZ 85260